ArticleParasitology research2026
Comparative palatability and efficacy of two praziquantel isomers in rainbow trout infected by eyefluke.
Article in Parasitology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Praziquantel is a widely used anthelmintic in both human and veterinary medicine, but low palatability of the commonly used compound, which is a mixture (M) of two isomers (D and L forms), may result in rejection of oral treatments. Purification of the D-isomer of praziquantel allows a comparative evaluation of both palatability and efficacy of the isomers. We showed that rainbow trout (Oncorhynchus mykiss) preferred feed containing D-PZQ feed (60% acceptance) compared to M-PZQ feed (20% acceptance) (inclusion of 400 g PZQ/kg feed). Subsequent efficacy studies using eyefluke Diplostomum pseudospathaceum cercariae (in vitro) and experimentally infected rainbow trout carrying metacercariae (in vivo) demonstrated a strong antiparasitic effect of both PZQ-forms. In vitro assays documented that both M-PZQ and D-PZQ induced rapid and concentration-dependent mortality in cercaria (100% within 4 h in 0.125 mg PZQ/L), but with a significantly higher killing rate of of D-PZQ. In vivo assays (17 days feeding medicated feed) showed significant efficacy of both D-PZQ and M-PZQ. A slightly (non-significant) faster effect of D-PZQ may partly be ascribed to a combination of higher consumption of this isomer (due to its higher palatability) and higher efficacy. Cataract formation occurred in control fish but was prevented by both drug types indicating that metabolic and/or mechanical activities of live parasites are associated with cataract induction. This rainbow trout/eyefluke infection may serve as a model for non-piscine host-parasite systems as well.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.